View Online
April 25, 2019
News From Medscape
The following recommended articles on are freely available through the partnership between ABC and Medscape, no registration or login required.
Paclitaxel-Based Devices in PAD: Operating Under a Dark Cloud
Professional societies in the United States and Europe are changing their stance on the use of paclitaxel-based balloons and stents to treat peripheral artery disease (PAD) after the US Food and Drug Administration's (FDA) recommendation to consider "alternative treatment options" for most patients.
Housework Leads Some Proceduralist Moms to Rethink Specialty
Physician mothers have more responsibilities around the home than their partners or spouses, which is not surprising. But among physician mothers in surgical specialties, those with heavier loads at home were more likely to say they were dissatisfied with their careers compared with those with fewer domestic responsibilities.
Texas Tech Agrees to Stop Using Race in Med School Admissions
The agreement — which includes only Texas Tech's medical school — is the end result of a complaint lodged in 2005 by antiaffirmative-action activist Roger Clegg, chief executive officer of the Center for Equal Opportunity.
Items of Interest
Preventive Cardio-Oncology: The Rise of Prehabilitation
By Sherry-Ann Brown, MD, PHD
Take a step back from the idea of preventive cardio-oncology in breast cancer or any other cancer and first consider how far we have come in the broader field of cardio-oncology.
ACP Lays Out Plan to Redesign Affordable Care Act
The American College of Physicians (ACP) wants to strengthen the Affordable Care Act (ACA) by scrapping the cap on premium tax credits, adding a public plan option, and re-enrolling people automatically. Their recommendations were published online on Monday in a position paper in the Annals of Internal Medicine, just after the ACP Internal Medicine (IM) Meeting 2019.
Prior Authorization Bill Expected in Congress This Summer
Bipartisan legislation to ease the burden of prior authorization is expected to be introduced in the House this summer, a Republican staffer said. "We've been working with [Reps.] Mike Kelly (R-Pa.) and Suzan DelBene (D-Wash.) on prior authorization," said Charlotte Pineda, healthcare advisor to Rep. Roger Marshall, MD (R-Kan.), an ob/gyn, during a conference on free-market healthcare here earlier this month.
Multisociety Consensus Statement Tackles the Classification of Heart Valve Centers
More and more hospitals are beginning to offer valvular heart disease procedures, raising questions over how to structure care delivery on a system-wide level. To add some clarity, a multidisciplinary group recently created a consensus document that delineates between primary and comprehensive centers.
FDA Approves Lotus Edge, Ushering Third Device Into US Market
The US Food and Drug Administration has approved the Lotus Edge aortic valve system for transcatheter aortic valve replacement in patients at high risk for surgery, bringing—at long last—a third commercial player, Boston Scientific, into this space.
Featured Articles by Members
ABC Members: We welcome your published research submissions and articles for inclusion in future issues of Clinical Updates and Insights. Email Rachel Williams at and please attach file or include links to the original published work and/or abstract.
Impact of Race and Ethnicity on the Clinical and Angiographic Characteristics, Social Determinants of Health, and 1-Year Outcomes After Everolimus-Eluting Coronary Stent Procedures in Women
Co-authored by lead author Roxana Mehran, Paul Underwood and Wayne Batchelor (with Jaya Chandrasekhar, Scott Davis, Sandeep Nathan, Roger Hill, Steven Hearne, Vince Vismara, Robert Pyo, Elie Gharib, Zafir Hawa, George Chrysant, David Kandzari and
The impact of race/ethnicity on coronary stent outcomes in women is unknown. They compared baseline characteristics, social determinants of health, and 1-year outcomes in female African Americans (AA) and Hispanic/Latinas (HL) versus white women after coronary everolimus-eluting stent implantation in all-comer patients.
The Diversity Snowball Effect: The Quest to Increase Diversity in Emergency Medicine: A Case Study of Highland's Emergency Medicine Residency Program
Co-authored by Jocelyn Freeman Garrick, MD, MS (Berenice Perez, MD, Tiffany C. Anaebere, MD, Petrina Craine, MD, Claire Lyons, MD and Tammy Lee, MPH)
This article is a review of the strategies used to diversify the Highland EM Residency Program. Most components can be applied across emergency medicine programs to increase the number of underrepresented minority residents and potentially improve health outcomes for diverse populations.
Spontaneous Coronary Artery Dissection: An Often Unrecognized Cause of Acute Coronary Syndrome
Co-authored by Dwight Dishmon, MD (with Nureddin K. Almaddah, MD, Mohamed S. Morsy, MD and Rami N. Khouzam, MD, FACC, FACP, FASNC, FASE, FSCAI)
Spontaneous coronary artery dissection (SCAD), an intramural hemorrhage leading to a separation of the layers of the coronary artery wall, is traditionally considered a rare condition associated mainly with pregnancy but is likely underdiagnosed in other settings. Its recognition by coronary angiography is key.
Changes in Thromboinflammatory Profiles Across the Generations of Transcatheter Aortic Heart Valves.
Co-authored by Donald Lynch (with Travis Sexton, Maria Alkhasova, Marcielle de Beer and Susan Smyth)
Evolution of the TAVR technology has occurred rapidly over the last 5 years. The newer devices and smaller delivery systems are associated with less systemic inflammation, as reflected in WBC and plasma IL-6 levels. However, the acute phase reactant SAA remains unchanged, possibly reflecting different triggers for SAA following TAVR.
Upcoming Events
ACCOuNT Pilot Grant Application
The African American Pharmacogenomic Consortium Network Transdisciplinary Collaborative Center (ACCOuNT TCC) – a partnership between ITM investigators and Northwestern University – is offering a Pilot Grant Program to stimulate community stakeholders to be the principal drivers of pharmacogenomics-enabling research projects that they conceive, plan, and execute with support from research collaborators.
Two projects focused on African American cardiovascular pharmacogenomics, or how a person’s genes impact their reaction to drugs for the heart and blood vessels, will be awarded each year. Awards will be made for up to $25,000 for each project.
The applications must be submitted by April 26, 2019 at 5:00pm.

In addition to community-based organizations and clinician investigators, the organization is encouraging voluntary health organizations and public health departments to apply for funding. For more information please visit the link below.

Summer Training For Underrepresented Junior Facilty
Washington University in St. Louis School of Medicine offers an all-expense paid summer institute program, initiated and funded by the NHLBI, to increase diversity in the field of Cardiovascular Disease Comorbidities, Genetics and Epidemiology.
Program Includes:
Two consecutive summers with two-week all-expense paid
summer institute, Mid-Year & Annual Meeting to:

  • Establish partnerships between Mentors and Mentees based on mutualresearch interests

  • Participate in training via lectures and workshops on various topics relatedto Cardiovascular Disease Comorbidities, Genetics, and Epidemiology

  • Participate in special grant-writing sessions conducted by NHLBI scientificprogram staff and PRIDE faculty

  • Compete for Small Research Project (SRP) funding for generatingpreliminary data for subsequent NHLBI grant applications

  • Develop the skills needed to apply for research grants and promoting asustainable independent research program for career development
This email was sent to ##email## by Association of Black Cardiologists, powered by Powered by Multiview's Content Marketing
Engage your customer base. Launch your Content Marketing program today.
Archive | View Online | Unsubscribe | Subscribe